Slide background
Absynth Biologics

Absynth Biologics

Developing innovative vaccines to prevent bacterial infections to address the challenge of antimicrobial resistance


Presenter:

Fiona Marston, CEO

Active Needle

Active Needle

Enabling clinicians to perform needle based procedures safely and efficiently benefiting patients and healthcare providers


Presenter:

Michael Hawley, Chairman

Alchemy Pharmatech

Alchemy Pharmatech

An innovation-driven company developing drug delivery platforms in partnership with the pharmaceutical industry.


Presenter:

Ian Harrison, CSO

Antikor

Antikor

Exploiting a novel technology platform called OptiLinked-FDCs, to generate revolutionary products to treat solid cancers


Presenter:

Till Medinger, Chairman

AsDerCo

AsDerCo

Developing and marketing a portfolio of dermatological products.


Presenter:

Pascal Nizet, CEO

Avicenna Oncology

Avicenna Oncology

Dedicated to the scouting acquisition & development of new generation of payloads for oncology targeted therapeutics


Presenter:

Zaki Sellam, CEO

Balmes Transplantation

Balmes Transplantation

Specializing in the development of pharmaceutical therapeutics


Presenter:

Guillaume Demarne, Business Development Officer

Barts Cancer Institute

Barts Cancer Institute

Barts Cancer Institute has a long tradition of pioneering research and innovation. Many surgical procedures were first discovered here as well as the use of radiotherapy to treat cancer


Presenter:

David Britton, Kinomica | Jesmond Dalli, Resolomics

Biopsys

Biopsys

Developing a Raman spectroscopy needle probe and endoscope


Presenter:

Nick Stone, Biopsys

Biosignatures

Biosignatures

Identifying patterns of proteins (or biosignatures) specific to a disease using statistical methods


Presenter:

Keith Milton, CFO

Biovorn Ltd

Biovorn Ltd

Continuing research into a number of compounds previously used by its founders in non-related fields


Presenter:

Jerome Vaughan, CEO

Brunel University London

Brunel University London

Presenter:

Mike Themis, Founder, TestaVec (BUL Spinout)